Analysts Set Oruka Therapeutics, Inc. (NASDAQ:ORKA) Price Target at $40.38
Shares of Oruka Therapeutics, Inc. (NASDAQ:ORKA – Get Free Report) have earned an average rating of “Buy” from the ten analysts that are presently covering the firm, Marketbeat.com reports. Eight equities research analysts have rated the stock with a buy recommendation and two have assigned a strong buy recommendation to the company. The average 12 […]
Shares of Oruka Therapeutics, Inc. (NASDAQ:ORKA – Get Free Report) have earned an average rating of “Buy” from the ten analysts that are presently covering the firm, Marketbeat.com reports. Eight equities research analysts have rated the stock with a buy recommendation and two have assigned a strong buy recommendation to the company. The average 12 […]
